Over the years, WEMBLEY MEDICAL has been honored to receive strong support and collaboration from the Scientific Advisory Board, which comprises leading Professors, Doctors, and Physicians in the medical field. The Board’s involvement not only contributes expertise and strategic direction but also serves as a driving force for sustainable development and the continuous improvement of WEMBLEY MEDICAL's product quality.

The Scientific Advisory Board has become an integral part of WEMBLEY MEDICAL’s long-term development strategy. The in-depth knowledge and extensive practical experience of the experts on the Board have enabled the company to continuously innovate, optimize production processes, and provide high-quality medical products that meet stringent international standards and the rapid growth of the healthcare industry.

WEMBLEY MEDICAL's Scientific Advisory Board brings together leading medical experts in Vietnam, including:

• People's Doctor, Prof. Pr.D. Dr. Ngo Minh Xuan, Chairman of the Training Science Council, former Party Secretary, Former Rector, and Former Chairman of the Pham Ngoc Thach University of Medicine, serving as Chairman of the WEMBLEY MEDICAL Scientific Advisory Board.
• People's Doctor, Prof. Pr.D. Dr. Tran Quyet Tien, Vice Rector of the University of Health Sciences - National University of Ho Chi Minh City, serving as a Member of the WEMBLEY MEDICAL Scientific Advisory Board.
• Assoc. Prof. Dr. Le Hoai Quoc, Chairman of the Ho Chi Minh City Automation Association, Member of the Ho Chi Minh City Science Council, serving as a Member of the WEMBLEY MEDICAL Scientific Advisory Board.

The contributions of the experts on the Advisory Board have enabled WEMBLEY MEDICAL to achieve significant milestones, solidifying its position in the medical industry. The company remains committed to maintaining and further developing its close collaboration with the Board, aiming to continuously enhance its core values and make a positive contribution to the growth of Vietnam's healthcare sector.

• Enhancing Product Quality: WEMBLEY MEDICAL is committed to applying the most advanced technologies, strictly adhering to international standards, and continuously improving production processes to ensure that every product achieves the highest quality, effectively meeting the healthcare needs of the community.
• Developing New Products: The company strives to lead in identifying emerging trends in the healthcare industry, researching and developing breakthrough products that deliver optimal treatment outcomes and contribute to improving the quality of life for patients.
• Training and Developing Human Resources: WEMBLEY MEDICAL places great emphasis on training and enhancing the professional competence of its staff, building a strong, creative workforce that stays up-to-date with the latest advancements in the medical field.
• Expanding International Cooperation: WEMBLEY MEDICAL continuously seeks to establish strategic partnerships with both domestic and international collaborators, with the goal of enhancing its position and influence in the global market.

Ms. Tran Thi Ngoc Thuy, Chairwoman of the Board and CEO of WEMBLEY MEDICAL, shared: “We are extremely proud and grateful to collaborate with experts in the medical field. The advice and contributions from the Scientific Advisory Board over the years have strengthened WEMBLEY MEDICAL’s standing, reaffirming our commitment to delivering high-quality medical products and positively contributing to the improvement of public health.”

People's Doctor, Prof. Pr.D. Dr. Ngo Minh Xuan, also expressed: “I am highly impressed with WEMBLEY MEDICAL’s continuous efforts to develop domestic medical products. With the support of the Scientific Advisory Board, I believe that WEMBLEY MEDICAL will achieve even greater success in the future.”

WEMBLEY MEDICAL extends its deep gratitude to the Scientific Advisory Board for their collaboration. We firmly believe that, with this meaningful partnership, WEMBLEY MEDICAL will fulfill its mission to “create a future where everyone has access to high-quality medical products without financial or resource limitations.”